misleading guidance

Class action lawsuit filed against $MEDP over missed Q4 2025 book-to-bill guidance. Stock fell 16% on February 9, 2026. Lead plaintiff deadline set for June 8, 2026.

Law firm Levi & Korsinsky files class action against $GTN, alleging management concealed contract value growth deterioration from 7% to 1%, causing 52% stock decline.

Boston Scientific faces class action lawsuit alleging management concealed adverse trends in electrophysiology segment's procedure volumes and competitive pressures from July 2025 to February 2026.

Federal securities lawsuit filed against Camping World Holdings for allegedly overstating inventory capabilities. Stock dropped 24.8% and 16.5% in Q3-Q4 2025; investors have until May 11, 2026 to join.

Robbins Geller files class action against monday.com ($MNDY) alleging false revenue projections. Stock plunged 21% after company withdrew 2027 guidance.

Portnoy Law Firm sues BellRing Brands for allegedly inflating organic sales growth through customer inventory stockpiling, citing 52% stock decline following revelations.

Boston Scientific faces class action over false electrophysiology segment statements. Investors from July 2025–February 2026 may recover damages; lead plaintiff deadline May 4, 2026.

Rosen Law Firm alerts $EOSE investors of May 5 deadline to join securities lawsuit alleging false production capacity and guidance statements.

Securities lawsuit alleges $BSX made false statements about electrophysiology sustainability. Investors who bought stock July 2025-February 2026 may qualify for compensation.

Class action lawsuit alleges Boston Scientific made false statements about U.S. electrophysiology segment sustainability, citing undisclosed competitive pressures and regulatory headwinds affecting procedure volumes.

Eos Energy Enterprises faces class action lawsuit alleging undisclosed production ramp failures and quality issues misled investors between November 2025 and February 2026.

Eos Energy Enterprises faces class action lawsuit after 2025 revenue missed guidance by 24%, falling to $114.2M. Stock collapsed 39%; investors can claim lead plaintiff status by May 5, 2026.

Securities class action filed against PayPal for allegedly misleading investors on revenue outlook. Stock fell over 20% after disappointing February 2026 earnings and unachievable 2027 targets.

Class action filed against $BSX alleging executives misrepresented U.S. electrophysiology segment sustainability. Claims executives concealed adverse trends, competitive pressures, regulatory challenges.

Class action lawsuit filed against PayPal for allegedly misleading investors. Stock fell over 20% after disappointing Q4 2025 earnings and guidance withdrawal.

Robbins Geller files class action against Varonis Systems ($VRNS) alleging investor fraud over Q3 2025 missed guidance. Stock plummeted 49%; lead plaintiff deadline set for March 9, 2026.

$PYPL faces class action lawsuit over allegedly false revenue projections. Stock plunged 20% after disappointing earnings and guidance withdrawal in February 2026.

Robbins LLP files class action against $BBWI over alleged investor deception regarding growth strategy. Q3 miss triggered 24.8% stock decline.

PayPal faces securities fraud lawsuit for allegedly misleading investors about growth targets and revenue outlook. Stock fell 20% after disappointing earnings and CEO departure.

Class action filed against BellRing for allegedly misrepresenting sales growth through customer inventory buildup. Stock fell 33% after weaker-than-expected 2025 outlook disclosure.